Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291408
Recruitment Status : Withdrawn (Researchers left the institute)
First Posted : February 14, 2006
Last Update Posted : August 7, 2019
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Imperial College London

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : June 2007